Your browser doesn't support javascript.
loading
Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics.
Gangji, Rahaman Navaz; Sankaranarayanan, Nehru Viji; Elste, James; Al-Horani, Rami A; Afosah, Daniel K; Joshi, Rachel; Tiwari, Vaibhav; Desai, Umesh R.
Afiliación
  • Gangji RN; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States.
  • Sankaranarayanan NV; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States.
  • Elste J; Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298, United States.
  • Al-Horani RA; Department of Microbiology and Immunology, Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, Illinois 60515, United States.
  • Afosah DK; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States.
  • Joshi R; College of Pharmacy, Xavier University of Louisiana, New Orleans, Louisiana 70125, United States.
  • Tiwari V; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States.
  • Desai UR; Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298, United States.
ACS Med Chem Lett ; 9(8): 797-802, 2018 Aug 09.
Article en En | MEDLINE | ID: mdl-30128070
ABSTRACT
Although heparan sulfate (HS) has been implicated in facilitating entry of enveloped viruses including herpes simplex virus (HSV), small molecules that effectively compete with this abundant, cell surface macromolecule remain unknown. We reasoned that entry of HSV-1 involving its glycoprotein D (gD) binding to HS could be competitively targeted through small, synthetic, nonsaccharide glycosaminoglycan mimetics (NSGMs). Screening a library of NSGMs identified a small, distinct group that bound gD with affinities of 8-120 nM. Studies on HSV-1 entry into HeLa, HFF-1, and VK2/E6E7 cells identified inhibitors with potencies in the range of 0.4-1.0 µM. These synthetic NSGMs are likely to offer promising chemical biology probes and/or antiviral drug discovery opportunities.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2018 Tipo del documento: Article